|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Ziprasidone for thetreatment of acute manic or mixed episodes associated withbipolardisorder显示文摘 | Warrington L Lombardo I Loebel A | 2007 | CNS Drugs2007，21，10： | 1 |
| 2 | Lurasidone monotherapy for the treatment of bipolar I depression: results of a 6-week, double-blind, placebo-controlled study 显示文摘 | Loebel A Cucchiaro J Silva R | 2014 | Am J Psychiatry2014，171，2： | 1 |
| 3 | Efficacy and safetyof lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: a randomized, double-blind, placebo-and active-controlled trial显示文摘 | Loebel A Cucchiaro J Sarma K | 2013 | Schizophr Res2013，145，13： | 1 |
| 4 | Building the mouse gastru- la: signals, asymmetry and lineages 显示文摘 | Tam P P Loebel D A Tanaka S S | 2006 | Curr Opin Genet Dev2006，16，4： | 1 |
| 5 | Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression:a randomized,double-blind,placebo-controlled study显示文摘 | Loebel A Cucchiaro J Silva R | 2014 | Am J Psychiatry2014，171，2： | 1 |
| 6 | Lurasidone monotherapy in the treatment of bipolar I depression:a randomized,double-blind,placebo-controlled study显示文摘 | Loebel A Cucchiaro J Silva R | 2014 | Am J Psychiatry2014，171，2： | 1 |
| 7 | Efficacy of lurasidone in schizophrenia:summary of results from the clinical development program显示文摘 | Loebel A Cucchiaro J Ogasa M | | 0，，： | 1 |
| 8 | Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia:a randomized,double-blind,placebo-and active-controlled trial显示文摘 | Loebel A Cucchiaro J Sarma K | | 0，，： | 1 |
| 9 | Effectiveness of lurasidone vs quetiapine XR for relapse prevention in schizophrenia:a 12-month,double-blind,noninferiority study显示文摘 | Loebel A Cucchiaro J Xu J | | 0，，： | 1 |
| 10 | Hyperconnec- tivity and slow synapses during early development of medial prefrontal cortex in a mouse model for mental retardation and Autism显示文摘 | Testa silva G Loebel A Giugliano M | 2012 | Cereb Cortex2012，22，6： | 1 |
| 11 | Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double- blind, placebo- controlled study显示文摘 | LOEBEL A CUCCHIARO J SILVA R et d | 2014 | Am J Psychiatry2014，171，2： | 1 |
| 12 | Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized,doubleblind, placebo- controlled study显示文摘 | LOEBEL A CUCCHIARO J SILVA R et 01 | 2014 | Am J Psychiatry2014，171，2： | 1 |
| 13 | Lurasidone:a new drug in development for schizophrenia显示文摘 | Meyer J M Loebel A D Schweizer E | 2009 | Expert Opin Investig Drugs2009，18，11： | 1 |
| 14 | Weight effects associatedwith antipsychotics:a comprehensive database anlysis显示文摘 | Parsons B Allison DB Loebel A | 2009 | Schizo-phr Res2009，110，13： | 1 |
| 15 | Weight effects associated with anti- psychotics: A comprehensive database analysis 显示文摘 | Parsons B A Uison D B Loebel A | 2009 | Sehizophr Res2009，110，13： | 1 |
| 16 | Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: a randomized,double - blind, placebo- and active - controlled trial显示文摘 | LOEBEL A CUCCHIARO J SARMA K et ol | 2013 | Sehizophr Ras2013，145，13： | 1 |
| 17 | Duration of psychosis and outcome in first-episodes Chizophrenia显示文摘 | Loebel A Lieberrnan J A Alvir J M J | 1992 | Am J Psychiatry1992，149，： | 1 |
| 18 | Effectiveness of lurasidone vs quetiapine XR for relapse prevention in schizophrenia: a 12-month, double-blind, noninferiority study 显示文摘 | LOEBEL A CUCCHIARO J XU J | 2013 | Schizophr Res2013，147，1： | 1 |
| 19 | Duration of psychosis and outcome in first-episode schizophrenia 显示文摘 | Loebel A Lieberman JA Alvir JMJ | 1992 | Am J Psychiatry1992，20，149： | 1 |
| 20 | Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double- blind, placebo- controlled study显示文摘 | LOEBEL A CUCCHIARO J SILVA R et ol | 2014 | Am J Psychiatry2014，171，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员